ToxTa 100

ToxTa 100 – Innovative Botulinum Toxin for Safe and Effective Aesthetic Treatments

1. Product Overview & Manufacturer
ToxTa 100 is a botulinum toxin type A product developed by Jetema Co., Ltd., a reputable South Korean pharmaceutical and medical aesthetics company. Designed for precision, safety, and consistent results, ToxTa is a rising name in the global aesthetic medicine market, offering a reliable solution for both cosmetic and therapeutic treatments.

2. Packaging & Composition

• Each vial of ToxTa 100 contains 100 units of highly purified botulinum toxin type A in lyophilized (freeze-dried) powder form.

• It must be reconstituted with 0.9% sterile saline (NaCl) before administration.

3. Mechanism of Action
ToxTa works by blocking the release of acetylcholine at the neuromuscular junction. This process temporarily inhibits muscle contractions, leading to:

• Relaxation of facial muscles

• Reduction of dynamic wrinkles

• Prevention of excessive sweat gland activity

• Therapeutic muscle control

4. Key Features & Advantages

• High purity and stable formulation: Ensures consistent performance with minimal side effects.

• Fast onset: Noticeable effects typically start within 2–4 days post-treatment.

• Duration of action: Clinical effects can last around 3 to 6 months, depending on the area treated and individual response.

• Smooth and predictable diffusion, making it ideal for precise aesthetic applications.

• Cost-effective and increasingly used in international markets as a high-quality alternative to Western brands.

5. Clinical Applications

• Cosmetic Treatments:

  • Horizontal forehead lines

  • Glabellar lines (frown lines)

  • Crow’s feet

  • Bunny lines (nose wrinkles)

  • Masseter reduction (jaw slimming)

  • Chin dimpling and neck rejuvenation

• Therapeutic Uses:

  • Hyperhidrosis (excessive sweating in underarms, palms, or soles)

  • Muscle spasticity or localized dystonia (off-label)

  • Chronic migraine management (off-label)

6. Safety & Compliance

• Approved by the Korean MFDS (Ministry of Food and Drug Safety)

• Manufactured under GMP (Good Manufacturing Practice) standards

• Subject to rigorous quality control and purification protocols

• Well-tolerated with a low risk of adverse effects or immune resistance

7. Storage & Handling

• Store at 2–8°C, away from direct sunlight

• Do not freeze

• Use reconstituted solution within the timeframe recommended by the manufacturer

• Should be administered only by licensed medical professionals